(MENAFN- Gulf Times) Covid-19 vaccines tend to alleviate the symptoms of long Covid, according to a large survey of more than 800 people that suggests mRNA vaccines, in particular, are beneficial.
Though Covid-19 was initially understood to be a largely respiratory illness from which most would recover within a few weeks, as the pandemic wore on increasing numbers of people reported experiencing symptoms for months on end.
There is no consensus definition of the condition of these people who have symptoms ranging from chronic fatigue to organ damage, let alone a standardised treatment plan.
As vaccines hit the mainstream, concerns arose that vaccination could precipitate relapses or a worsening of symptoms.
But conversely, anecdotal reports suggested that vaccines helped some people with long Covid. The analysis, which is yet to be peer reviewed, was based on a survey conducted by the advocacy group LongCovidSOS involving 812 people (mostly white, female participants) with long Covid in the UK and internationally, who were contacted via social media.
The participants (a small proportion of whom also said they had ME/CFS) were asked to wait at least a week after their first dose to avoid their responses conflating with side-effects of the vaccine. Scores across 14 common long-Covid symptoms were compared before and after the first vaccine dose.
Data showed that 56.7% of respondents experienced an overall improvement in symptoms, with 24.6% remaining unchanged and 18.7% reporting a deterioration in their symptoms. In general, those who received mRNA vaccines (Pfizer/BioNTech or Moderna) reported more improvements in symptoms, compared with those who got an adenovirus vaccine (Oxford/AstraZeneca).
In particular, those who received the Moderna vaccine were more likely to see improvements in symptoms such as fatigue, brain fog and muscle pain, and less likely to report a deterioration, the analysis found.
''This survey will reassure people that they would have to be quite unlucky to really have an overall worsening of symptoms,” said analysis author Ondine Sherwood, from the patient advocacy group LongCovidSOS.
''The data is very encouraging, but we don’t know how long the benefits last.” Dr David Strain, also an analysis author and a senior clinical lecturer at the University of Exeter medical school, said: ''There isn’t a blood pressure tablet that fixes everybody … and similarly, there’s not one long-Covid treatment that’s going to fix everyone – but the fact that one treatment does fix something means that there’s bound to be other treatments out there that will fix others.”
MENAFN18052021000067011011ID1102098061
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.